|
1
|
Kim JH: Chemotherapy for colorectal cancer
in the elderly. World J Gastroenterol. 21:5158–5166. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Davidson M, Okines AF and Starling N:
Current and Future Therapies for Advanced Gastric Cancer. Clin
Colorectal Cancer. 14:239–250. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang L, Ngo JA, Wetzel MD and Marchetti
D: Heparanase mediates a novel mechanism in lapatinib-resistant
brain metastatic breast cancer. Neoplasia. 17:101–113. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jin AH and Wei ZL: Molecular mechanism of
increased sensitivity of cisplatin to ovarian cancer by inhibition
of microRNA-23a expression. Int J Clin Exp Med. 8:13329–13334.
2015.PubMed/NCBI
|
|
5
|
Wu Z, Zhang Z, Ge X, Lin Y, Dai C, Chang
J, Liu X, Geng R, Wang C, Chen H, et al: Identification of
short-form RON as a novel intrinsic resistance mechanism for
anti-MET therapy in MET-positive gastric cancer. Oncotarget.
6:40519–40534. 2015.PubMed/NCBI
|
|
6
|
Ho CM, Huang CJ, Huang SH, Chang SF and
Cheng WF: Demethylation of HIN-1 reverses paclitaxel-resistance of
ovarian clear cell carcinoma through the AKT-mTOR signaling
pathway. BMC Cancer. 15:7892015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jung SO, Kim SY, Kim JO, Jung SS, Park HS,
Moon JY, Kim SM and Lee JE: Promising effects of 3rd line
cyclophosphamide, adriamycin and vincristine (CAV) and 4th line
ifosfamide and carboplatin chemotherapy in refractory small cell
lung cancer. Thorac Cancer. 6:659–663. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chau TL, Gioia R, Gatot JS, Patrascu F,
Carpentier I, Chapelle JP, O'Neill L, Beyaert R, Piette J and
Chariot A: Are the IKKs and IKK-related kinases TBK1 and
IKK-epsilon similarly activated? Trends Biochem Sci. 33:171–180.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang J, Liu T, Xu LG, Chen D, Zhai Z and
Shu HB: SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3-
and virus-triggered IRF-3 activation pathways. EMBO J.
24:4018–4028. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hsieh JY, Huang TS, Cheng SM, Lin WS, Tsai
TN, Lee OK and Wang HW: miR-146a-5p circuitry uncouples cell
proliferation and migration, but not differentiation, in human
mesenchymal stem cells. Nucleic Acids Res. 41:9753–9763. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun QL, Zhao CP, Wang TY, Hao XB, Wang XY,
Zhang X and Li YC: Expression profile analysis of long non-coding
RNA associated with vincristine resistance in colon cancer cells by
next-generation sequencing. Gene. 572:79–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCt Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dong WH, Wang TY, Wang F and Zhang JH:
Simple, time-saving dye staining of proteins for sodium dodecyl
sulfate-polyacrylamide gel electrophoresis using Coomassie blue.
PLoS One. 6:e223942011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chao MW, Lai MJ, Liou JP, Chang YL, Wang
JC, Pan SL and Teng CM: The synergic effect of vincristine and
vorinostat in leukemia in vitro and in vivo. J Hematol Oncol.
8:822015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lewis RS, Fidel J, Dassanayake S, Court
MH, Burke NS and Mealey KL: Comparison of chemotherapeutic drug
resistance in cells transfected with canine ABCG2 or feline ABCG2.
Vet Comp Oncol. Oct 14–2015.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu Y and Qiu L: Nonspecifically enhanced
therapeutic effects of vincristine on multidrug-resistant cancers
when coencapsulated with quinine in liposomes. Int J Nanomedicine.
10:4225–4237. 2015.PubMed/NCBI
|
|
17
|
Martins A, Sipos P, Dér K, Csábi J, Miklos
W, Berger W, Zalatnai A, Amaral L, Molnár J, Szabó-Révész P and
Hunyadi A: Ecdysteroids sensitize MDR and non-MDR cancer cell lines
to doxorubicin, paclitaxel, and vincristine but tend to protect
them from cisplatin. Biomed Res Int. 2015:8953602015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bartram I, Erben U, Ortiz-Tanchez J,
Blunert K, Schlee C, Neumann M, Heesch S and Baldus CD: Inhibition
of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in
T-ALL. BMC Cancer. 15:6632015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tivnan A, Zakaria Z, O'Leary C, Kögel D,
Pokorny JL, Sarkaria JN and Prehn JH: Inhibition of multidrug
resistance protein 1 (MRP1) improves chemotherapy drug response in
primary and recurrent glioblastoma multiforme. Front Neurosci.
9:2182015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsubaki M, Takeda T, Ogawa N, Sakamoto K,
Shimaoka H, Fujita A, Itoh T, Imano M, Ishizaka T, Satou T, et al:
Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB
plays a central role in vincristine resistance in multiple myeloma
cells. Leuk Res. 39:445–452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moqadam F Akbari, Lange-Turenhout EA,
Ariës IM, Pieters R and den Boer ML: miR-125b, miR-100 and miR-99a
co-regulate vincristine resistance in childhood acute lymphoblastic
leukemia. Leuk Res. 37:1315–1321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang TY, Zhang QQ, Zhang X, Sun QL, Zhao
CP and Wang XY: The effect of recombinant lentiviral vector
encoding miR-145 on human esophageal cancer cells. Tumour Biol.
36:9733–9738. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu Y, Xia F, Ma L, Shan J, Shen J, Yang Z,
Liu J, Cui Y, Bian X, Bie P, et al: MicroRNA-122 sensitizes HCC
cancer cells to adriamycin and vincristine through modulating
expression of MDR and inducing cell cycle arrest. Cancer Lett.
310:160–169. 2011.PubMed/NCBI
|
|
24
|
Méndez C, Ahlenstiel CL and Kelleher AD:
Post-transcriptional gene silencing, transcriptional gene silencing
and human immunodeficiency virus. World J Virol. 4:219–244. 2015.
View Article : Google Scholar : PubMed/NCBI
|
